Open AccessDexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review protocol
Author(s) -
Marco Fiore,
Giacomo Torretta,
Maria Beatrice Passavanti,
Pasquale Sansone,
Maria Caterina Pace,
Aniello Alfieri,
Caterina Aurilio,
Vittorio Simeon,
Paolo Chiodini,
Vincenzo Pota
Publication year - 2019
Publication title -
jbi database of systematic reviews and implementation reports
Language(s) - English
Resource type - Journals
ISSN - 2202-4433
DOI - 10.11124/jbisrir-2017-003949
Subject(s) - dexmedetomidine , medicine , alcohol withdrawal syndrome , randomized controlled trial , adjunctive treatment , intensive care medicine , sedation , anesthesia , biochemistry , chemistry , alcohol
The purpose of this review is to evaluate the effectiveness and safety of dexmedetomidine as adjunctive therapy to the standard of care (benzodiazepines) compared to either the standard of care or other adjunctive treatment approaches (e.g. benzodiazepines plus propofol) for the treatment of alcohol withdrawal syndrome (AWS).